Cencora ROE 2010-2024 | COR

Current and historical return on equity (ROE) values for Cencora (COR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Cencora ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $1.85B $1.23B 191.33%
2023-12-31 $1.87B $1.06B 236.46%
2023-09-30 $1.75B $0.67B 321.40%
2023-06-30 $1.69B $0.92B 428.39%
2023-03-31 $1.62B $0.51B 550.94%
2022-12-31 $1.73B $0.07B 441.05%
2022-09-30 $1.70B $0.07B 324.24%
2022-06-30 $1.84B $0.52B 282.41%
2022-03-31 $1.73B $0.91B 276.43%
2021-12-31 $1.61B $0.60B 433.29%
2021-09-30 $1.54B $0.58B 1633.95%
2021-06-30 $-3.74B $0.41B 1430.37%
2021-03-31 $-3.75B $-0.10B -596.42%
2020-12-31 $-3.22B $-0.51B -203.89%
2020-09-30 $-3.41B $-0.84B -137.71%
2020-06-30 $1.57B $3.97B 45.72%
2020-03-31 $1.58B $3.71B 49.18%
2019-12-31 $0.65B $3.07B 21.30%
2019-09-30 $0.86B $2.99B 27.83%
2019-06-30 $0.96B $3.11B 30.94%
2019-03-31 $0.93B $3.04B 29.69%
2018-12-31 $1.19B $3.17B 37.03%
2018-09-30 $1.66B $3.05B 52.78%
2018-06-30 $1.08B $3.28B 37.31%
2018-03-31 $0.85B $3.36B 31.46%
2017-12-31 $0.98B $2.88B 39.03%
2017-09-30 $0.36B $2.06B 15.67%
2017-06-30 $0.85B $2.55B 36.62%
2017-03-31 $1.15B $2.53B 53.29%
2016-12-31 $1.35B $2.12B 64.69%
2016-09-30 $1.43B $2.13B 76.17%
2016-06-30 $1.64B $1.88B 109.79%
2016-03-31 $1.51B $2.19B 106.14%
2015-12-31 $0.39B $1.30B 28.99%
2015-09-30 $-0.14B $0.62B -9.39%
2015-06-30 $-0.43B $1.58B -24.00%
2015-03-31 $-0.66B $1.92B -34.61%
2014-12-31 $0.03B $1.77B 1.68%
2014-09-30 $0.27B $1.96B 13.15%
2014-06-30 $0.26B $1.99B 11.91%
2014-03-31 $0.44B $2.15B 19.27%
2013-12-31 $0.31B $2.25B 13.12%
2013-09-30 $0.43B $2.32B 18.43%
2013-06-30 $0.55B $2.42B 22.85%
2013-03-31 $0.56B $2.35B 22.21%
2012-12-31 $0.73B $2.34B 27.18%
2012-09-30 $0.72B $2.46B 25.56%
2012-06-30 $0.70B $2.93B 24.11%
2012-03-31 $0.71B $2.95B 23.66%
2011-12-31 $0.71B $2.91B 23.36%
2011-09-30 $0.71B $2.87B 23.21%
2011-06-30 $0.70B $3.20B 22.85%
2011-03-31 $0.68B $3.13B 22.67%
2010-12-31 $0.65B $2.96B 22.13%
2010-09-30 $0.64B $2.95B 22.20%
2010-06-30 $0.63B $2.93B 22.28%
2010-03-31 $0.58B $2.83B 20.99%
2009-12-31 $0.54B $2.74B 19.75%
Sector Industry Market Cap Revenue
Medical Medical Services $45.072B $262.173B
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Viatris (VTRS) United States $13.931B 4.16
Revvity (RVTY) United States $13.772B 24.16
Natera (NTRA) United States $13.029B 0.00
Medpace Holdings (MEDP) United States $11.839B 35.92
Charles River Laboratories (CRL) United States $11.456B 21.93
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
CareDx (CDNA) United States $0.959B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00